Liao Carrie, Chief Accounting Officer at Definium Therapeutics ($DFTX), sold shares once on the open market in the last year, totaling about $15,800. Her most recent sale occurred on March 25, 2025. These sales rank 11,133rd among 11,678 insiders, far below the average of $8.6 million per person and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | S | Common Shares | 2347 | $6.74 | 144,923.0000 | 75,368,359 | 1.59% | 0.00% |
| March 12, 2025 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | A | Common Shares | 50000 | $0.00 | 142,270.0000 | 75,368,359 | 54.19% | 0.07% |
| Dec. 26, 2024 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | S | Common Shares | 2273 | $7.43 | 97,270.0000 | 0 | 2.28% | 0.00% |
| Sept. 25, 2024 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | S | Common Shares | 2352 | $5.98 | 99,543.0000 | 0 | 2.31% | 0.00% |
| Feb. 27, 2024 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | Chief Accounting Officer | A | Common Shares | 75000 | $0.00 | 101,895.0000 | 0 | 278.86% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Liao Carrie | VP, Controller&Acct Principal | A | Common Shares | 75000 | $0.00 | 478,430.0000 | 0 | 18.59% | 0.00% |